期刊文献+

凝血系统在脓毒症中的作用 被引量:3

The Effective of Coagulation System in Sepsis
在线阅读 下载PDF
导出
摘要 凝血系统异常在脓毒症发生、发展过程中具有重要作用,而脓毒症的主要病理生理学变化是严重全身感染引起的炎性反应过度激活及凝血功能障碍,二者相互作用,本文就这方面的研究进展简要综述,从发病机制上为脓毒症的临床治疗和预后提供思路。 The disorder of coagulation system has play an important role in the occurence and development of sepsis, in which the main pathophysiologieal changes are the over inflammatory reaction and coagulation disorders, as well as their interaction.This article reviews the progresses related to this in order to provide new ideas for clinical treatment and prognosis of sepsis from its pathogcnesis.
作者 周泽建
出处 《医学综述》 2006年第22期1361-1363,共3页 Medical Recapitulate
关键词 脓毒症 凝血系统 炎症 抗凝药 Sepsis Coagulation Inflammation Anticoagulant drugs
  • 相关文献

参考文献17

  • 1Napoleone E,Di Santo A,Bastone A,et al.Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells:a novel link between vascular inflammation and clotting activation[J].Arterioscler Thromb Vase Biol,2002,22(5):782-787.
  • 2李磊,汤耀卿.内皮细胞与脓毒症[J].生命科学,2005,17(3):236-239. 被引量:9
  • 3任霞,王字玲,周虹.血小板膜糖蛋白GPⅡb/Ⅲa的结构及激活机制研究进展[J].中国输血杂志,2005,18(2):159-161. 被引量:6
  • 4Key NS,Ely EW.Coagulation inhibition for sepsis[J].Curr Opin Hematol,2002,9(5):416-421.
  • 5刘秀娟,魏日胞,陈香美.白细胞介素6与凝血及血栓性疾病[J].中国实用内科杂志,2005,25(7):659-660. 被引量:3
  • 6Strukova SM.Thrombin as a regulator of inflammation and reparative processes in tissues[J].Biochemistry (Mosc),2001,66(1):8-18.
  • 7Szaba FM,Smiley ST.Roles for thrombiu and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo[J].Blood,2002,99(3):1053-1059.
  • 8Kinasewitz GT,Yan SB,Basson B,et al.Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis,regardless of causative micro-organism[ISRCTN74215569][J].Crit Care,2004,8(2):R82-90.
  • 9Faust SN,Levin M,Harrison OB,et al.Dysfunction of endothelial prorein C activation in severe meningococcal sepsis[J].N Engl J Med,2001,345(6):408-416.
  • 10Fourrier F.Recombinant human activated protein C in the treatment of severe sepsis:an evidence-based review[J].Crit Care Med,2004,32(11 Supp1):S534-541.

二级参考文献78

  • 1Greasey AA. New potential therapeutic modalities:tissue factor pathway in hibitor [ J]. Sepsis, 1999,3:173.
  • 2Shapira OM, Rene H, Lider O, et al. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin [J] .J Surg Res, 1999,85: 83.
  • 3Ozawa T, Yoshihara K, Koyama N, et al. Clinical efficacy of heparin-bonded bypass circuits relate to cytokine response in children [J]. Ann ThoracSurg, 2000,69: 584.
  • 4Hoppensteadt DA, Walenga JM, Fasanella A, et al. TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin [J]. Throm bosis Research, 1995,77:175.
  • 5William FN. Tissue factor pathway inhibitor[ J ]. Semin Thomb Hemost,1994,20:101.
  • 6Greasey AA, Chang AC,Fiegen L, et al. Tissue factor pathway inhibitor(TFPI) reduces morality from Escherichia coil septic shock [J] .J Clin Invest, 1993,91: 2850.
  • 7Esmon CT. Role of coagulation inhibitors inflammation [J]. Thromb Haemost, 2001,86: 51.
  • 8Abraham E. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis [J]. Crit Care Med,2000,9( ) :S31.
  • 9Xiong JP, Stehel T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin αVβ3. Science, 2001, 294(5541):339.
  • 10Deborah L French, Uri Seligsonhn. Platelet glycoprotein Ⅱ b/Ⅲa receptors and Glanzamn's thrombasthenia. Thromb Vascul Biol, 2000, 20(3):607.

共引文献17

同被引文献13

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部